{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:19:24Z","timestamp":1789085964896,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"crossref","award":["CL-2023-24-001"],"award-info":[{"award-number":["CL-2023-24-001"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24521-7","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:02:14Z","timestamp":1762516934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative risk of end-stage renal disease, myocardial infarction and stroke in young and older onset diabetes in UK Biobank"],"prefix":"10.1038","volume":"15","author":[{"given":"Debasish","family":"Kar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Molokhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Wierzbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania","family":"Koziell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Byng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Pinkney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedowra","family":"Zabeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubharthi","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Jonnagaddala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siaw-Teng","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"El-Wazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintu","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moien A. B.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"de Lusignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"24521_CR1","doi-asserted-by":"publisher","first-page":"111801","DOI":"10.1016\/j.diabres.2024.111801","volume":"215","author":"Y Yu","year":"2024","unstructured":"Yu, Y. et al. Global disease burden attributable to kidney dysfunction, 1990\u20132019: A health inequality and trend analysis based on the global burden of disease study. Diabetes Res. Clin. Practice 215, 111801 (2024).","journal-title":"Diabetes Res. Clin. Practice"},{"issue":"4","key":"24521_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-019-1133-6","volume":"19","author":"B Thomas","year":"2019","unstructured":"Thomas, B. The global burden of diabetic kidney disease: Time trends and gender gaps. Curr. Diab. Rep. 19(4), 1\u20137 (2019).","journal-title":"Curr. Diab. Rep."},{"issue":"15","key":"24521_CR3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani, A. et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N. Engl. J. Med. 376(15), 1407\u20131418 (2017).","journal-title":"N. Engl. J. Med."},{"key":"24521_CR4","unstructured":"24th Renal Registry Report. https:\/\/ukkidney.org\/audit-research\/annual-report\/24th-annual-report-data-31122020. (2022)."},{"key":"24521_CR5","unstructured":"UK Renal Registry summary fof annual report: Analyses of adult data to the end of 2021. https:\/\/ukkidney.org\/sites\/renal.org\/files\/UK%20Renal%20Registry%20Report%202021%20-%20Patient%20Summary_0.pdf. (2023)."},{"key":"24521_CR6","unstructured":"Renal registry UK 25th Annual report: UK Kidney Association. https:\/\/ukkidney.org\/audit-research\/annual-report. (2022)."},{"issue":"6","key":"24521_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1177\/08968608211061126","volume":"42","author":"G Roberts","year":"2022","unstructured":"Roberts, G. et al. Current costs of dialysis modalities: A comprehensive analysis within the United Kingdom. Perit. Dial. Int. 42(6), 578\u2013584 (2022).","journal-title":"Perit. Dial. Int."},{"issue":"2","key":"24521_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s42255-023-00970-0","volume":"6","author":"SH Kwak","year":"2024","unstructured":"Kwak, S. H. et al. Genetic architecture and biology of youth-onset type 2 diabetes. Nat. Metab. 6(2), 226\u2013237 (2024).","journal-title":"Nat. Metab."},{"key":"24521_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jpeds.2022.05.044","volume":"247","author":"S Srinivasan","year":"2022","unstructured":"Srinivasan, S. & Todd, J. The genetics of type 2 diabetes in youth: Where we are and the road ahead. J. Pediatr. 247, 17\u201321 (2022).","journal-title":"J. Pediatr."},{"issue":"6","key":"24521_CR10","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2337\/dc12-2393","volume":"36","author":"Group TS","year":"2013","unstructured":"Group TS. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and \u03b2-cell function in TODAY. Diabetes Care 36(6), 1749\u20131757 (2013).","journal-title":"Diabetes Care"},{"issue":"6","key":"24521_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41574-020-0334-z","volume":"16","author":"DJ Magliano","year":"2020","unstructured":"Magliano, D. J. et al. Young-onset type 2 diabetes mellitus\u2014Implications for morbidity and mortality. Nat. Rev. Endocrinol. 16(6), 321\u2013331 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"24521_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/pedi.12953","volume":"21","author":"T Barrett","year":"2020","unstructured":"Barrett, T. et al. Rapid progression of type 2 diabetes and related complications in children and young people\u2014A literature review. Pediatr. Diabetes 21(2), 158\u2013172 (2020).","journal-title":"Pediatr. Diabetes"},{"issue":"5","key":"24521_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel, V. T. & Shulman, G. I. Integrating mechanisms for insulin resistance: Common threads and missing links. Cell 148(5), 852\u2013871 (2012).","journal-title":"Cell"},{"issue":"8","key":"24521_CR14","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1210\/jc.2015-2192","volume":"100","author":"T Reinehr","year":"2015","unstructured":"Reinehr, T. et al. Fibroblast growth factor 21 and fetuin-A in obese adolescents with and without type 2 diabetes. J. Clin. Endocrinol. Metab. 100(8), 3004\u20133010 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"24521_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jpeds.2016.02.055","volume":"173","author":"T Reinehr","year":"2016","unstructured":"Reinehr, T. et al. Inflammatory markers in obese adolescents with type 2 diabetes and their relationship to hepatokines and adipokines. J. Pediatr. 173, 131\u2013135 (2016).","journal-title":"J. Pediatr."},{"issue":"3","key":"24521_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2337\/dc18-2021","volume":"42","author":"DM Scholtens","year":"2019","unstructured":"Scholtens, D. M. et al. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal glycemia and childhood glucose metabolism. Diabetes Care 42(3), 381\u2013392 (2019).","journal-title":"Diabetes Care"},{"issue":"3","key":"24521_CR17","first-page":"220","volume":"16","author":"B Valaiyapathi","year":"2020","unstructured":"Valaiyapathi, B., Gower, B. & Ashraf, A. P. Pathophysiology of type 2 diabetes in children and adolescents. Curr. Diabetes Rev. 16(3), 220\u2013229 (2020).","journal-title":"Curr. Diabetes Rev."},{"issue":"4","key":"24521_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2337\/dc18-1485","volume":"42","author":"P Finne","year":"2019","unstructured":"Finne, P. et al. Cumulative risk of end-stage renal disease among patients with type 2 diabetes: A nationwide inception cohort study. Diabetes Care 42(4), 539\u2013544 (2019).","journal-title":"Diabetes Care"},{"issue":"3","key":"24521_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.ackd.2014.03.003","volume":"21","author":"R P\u00e1lsson","year":"2014","unstructured":"P\u00e1lsson, R. & Patel, U. D. Cardiovascular complications of diabetic kidney disease. Adv. Chronic Kidney Dis. 21(3), 273\u2013280 (2014).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"24521_CR20","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1046\/j.1523-1755.64.s87.5.x","volume":"87","author":"AJ Collins","year":"2003","unstructured":"Collins, A. J. et al. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int. Suppl. 87, S24-31 (2003).","journal-title":"Kidney Int. Suppl."},{"issue":"13","key":"24521_CR21","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351(13), 1296\u20131305 (2004).","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"24521_CR22","doi-asserted-by":"publisher","first-page":"e011295","DOI":"10.1161\/JAHA.118.011295","volume":"8","author":"S Raghavan","year":"2019","unstructured":"Raghavan, S. et al. Diabetes mellitus-related all-cause and cardiovascular mortality in a national cohort of adults. J. Am. Heart Assoc. 8(4), e011295 (2019).","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"24521_CR23","doi-asserted-by":"publisher","first-page":"e0207960","DOI":"10.1371\/journal.pone.0207960","volume":"13","author":"NTQ Nguyen","year":"2018","unstructured":"Nguyen, N. T. Q. et al. Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England. PLoS ONE 13(11), e0207960 (2018).","journal-title":"PLoS ONE"},{"issue":"3","key":"24521_CR24","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12(3), e1001779 (2015).","journal-title":"PLoS Med."},{"issue":"5","key":"24521_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2337\/dc15-0991","volume":"39","author":"AH Al-Saeed","year":"2016","unstructured":"Al-Saeed, A. H. et al. An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: The impact of youth-onset type 2 diabetes. Diabetes Care 39(5), 823\u2013829 (2016).","journal-title":"Diabetes Care"},{"issue":"3","key":"24521_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/157016111203140518173700","volume":"12","author":"C Tsioufis","year":"2014","unstructured":"Tsioufis, C. et al. Effects of hypertension, diabetes mellitus, obesity and other factors on kidney haemodynamics. Curr. Vasc. Pharmacol. 12(3), 537\u2013548 (2014).","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"6","key":"24521_CR27","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey, A. S. et al. Definition and classification of chronic kidney disease: A position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int. 67(6), 2089\u20132100 (2005).","journal-title":"Kidney Int."},{"issue":"1","key":"24521_CR28","doi-asserted-by":"publisher","first-page":"e000172","DOI":"10.1136\/bmjph-2023-000172","volume":"1","author":"K Debasish","year":"2023","unstructured":"Debasish, K. et al. Relationship of cardiorenal risk factors with albuminuria based on age, smoking, glycaemic status and BMI: a retrospective cohort study of the UK Biobank data. BMJ Public Health 1(1), e000172 (2023).","journal-title":"BMJ Public Health"},{"issue":"4","key":"24521_CR29","first-page":"20","volume":"12","author":"R Herrera","year":"2010","unstructured":"Herrera, R. et al. Albuminuria as a marker of kidney and cardio-cerebral vascular damage. Isle of Youth Study (ISYS), Cuba. MEDICC Rev. 12(4), 20\u201326 (2010).","journal-title":"MEDICC Rev."},{"issue":"4","key":"24521_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/003693309704200401","volume":"42","author":"K McKenna","year":"1997","unstructured":"McKenna, K. & Thompson, C. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus. Scott. Med. J. 42(4), 99\u2013104 (1997).","journal-title":"Scott. Med. J."},{"key":"24521_CR31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S2213-8587(24)00242-0","volume":"12","author":"B Lin","year":"2024","unstructured":"Lin, B. et al. Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK prospective diabetes study (UKPDS) with up to 30 years of follow-up (UKPDS 92). Lancet Diabetes Endocrinol. 12, 904\u2013914 (2024).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"24521_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2016.11.006","volume":"123","author":"A Amutha","year":"2017","unstructured":"Amutha, A. et al. Incidence of complications in young-onset diabetes: Comparing type 2 with type 1 (the young diab study). Diabetes Res. Clin. Pract. 123, 1\u20138 (2017).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"5","key":"24521_CR33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMoa2100165","volume":"385","author":"Group TS","year":"2021","unstructured":"Group TS. Long-term complications in youth-onset type 2 diabetes. N. Engl. J. Med. 385(5), 416\u2013426 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"24521_CR34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2337\/dc13-0954","volume":"37","author":"AB Dart","year":"2014","unstructured":"Dart, A. B. et al. Earlier onset of complications in youth with type 2 diabetes. Diabetes Care 37(2), 436\u2013443 (2014).","journal-title":"Diabetes Care"},{"issue":"5","key":"24521_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/1479164114542802","volume":"11","author":"G Schernthaner","year":"2014","unstructured":"Schernthaner, G., Mogensen, C. E. & Schernthaner, G.-H. The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system. Diab. Vasc. Dis. Res. 11(5), 306\u2013323 (2014).","journal-title":"Diab. Vasc. Dis. Res."},{"key":"24521_CR36","unstructured":"SGLT2 inhibitors - heart failure and chronic kidney disease. (2025)."},{"issue":"3","key":"24521_CR37","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s12020-024-03772-w","volume":"85","author":"M Strati","year":"2024","unstructured":"Strati, M., Moustaki, M., Psaltopoulou, T., Vryonidou, A. & Paschou, S. A. Early onset type 2 diabetes mellitus: an update. Endocrine 85(3), 965\u2013978 (2024).","journal-title":"Endocrine"},{"issue":"11","key":"24521_CR38","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1007\/s00125-020-05273-7","volume":"63","author":"JJ Zhou","year":"2020","unstructured":"Zhou, J. J., Coleman, R., Holman, R. R. & Reaven, P. Long-term glucose variability and risk of nephropathy complication in UKPDS, ACCORD and VADT trials. Diabetologia 63(11), 2482\u20132485 (2020).","journal-title":"Diabetologia"},{"key":"24521_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.diabres.2017.02.007","volume":"128","author":"SR Dorajoo","year":"2017","unstructured":"Dorajoo, S. R. et al. HbA1c variability in type 2 diabetes is associated with the occurrence of new-onset albuminuria within three years. Diabetes Res. Clin. Pract. 128, 32\u201339 (2017).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"24521_CR40","doi-asserted-by":"publisher","first-page":"996","DOI":"10.2337\/db20-0443","volume":"70","author":"S Srinivasan","year":"2021","unstructured":"Srinivasan, S. et al. The first genome-wide association study for type 2 diabetes in youth: the Progress in Diabetes Genetics in Youth (ProDiGY) Consortium. Diabetes 70(4), 996\u20131005 (2021).","journal-title":"Diabetes"},{"issue":"10","key":"24521_CR41","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.2337\/dc21-0491","volume":"44","author":"JN Todd","year":"2021","unstructured":"Todd, J. N. et al. Monogenic diabetes in youth with presumed type 2 diabetes: results from the progress in diabetes genetics in youth (ProDiGY) collaboration. Diabetes Care 44(10), 2312\u20132319 (2021).","journal-title":"Diabetes Care"},{"issue":"10","key":"24521_CR42","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2337\/dbi20-0002","volume":"69","author":"JM Dennis","year":"2020","unstructured":"Dennis, J. M. Precision medicine in type 2 diabetes: Using individualized prediction models to optimize selection of treatment. Diabetes 69(10), 2075\u20132085 (2020).","journal-title":"Diabetes"},{"key":"24521_CR43","unstructured":"How many people in the UK have diabetes?: Diabetes UK; https:\/\/www.diabetes.org.uk\/about-us\/about-the-charity\/our-strategy\/statistics."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24521-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24521-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24521-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:02:16Z","timestamp":1762516936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24521-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24521"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24521-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The UK Biobank received ethical approval from the Northwest Multicentre Research Ethics Committee (REC reference 11\/NW\/03820), and all participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All UKB study participants consented to their data being used for medical research and publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"39073"}}